Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konrad Lewandowski

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Przeglad Gastroenterologiczny|January 15, 2025
Ophthalmological manifestations in inflammatory bowel disease under the watchful eye of a gastroenterologist from a tertiary centreKonrad Lewandowski, Magdalena Kaniewska, Katarzyna Karłowicz, et al.
Polish Archives of Internal Medicine|July 1, 2024
Dermal lesions associated with anti-tumor necrosis factor α therapy in patients with inflammatory bowel disease (IBD): findings from a tertiary IBD center in PolandKonrad Lewandowski, Magdalena Kaniewska, Martyna Więcek, et al.
Pharmacological Reports : PR|April 17, 2024
Pharmacokinetic interaction between regorafenib and atorvastatin in ratsDanuta Szkutnik-Fiedler, Edyta Szałek, Filip Otto, et al.
Przeglad Gastroenterologiczny|June 28, 2024
SARS-CoV-2 vaccination in inflammatory bowel disease (IBD) patients - does treatment for IBD negatively affect SARS-CoV-2 antibodies? A single-centre, prospective studyKatarzyna Karłowicz, Konrad Lewandowski, Edyta Tulewicz-Marti, et al.
Gastrointestinal Endoscopy|March 5, 2025
Risk factors for difficult endoscopic bowel dilation of predominantly shorter and noninflammatory strictures among patients with inflammatory bowel disease: findings from inflammatory bowel disease tertiary centers in Poland and Czech RepublicKonrad Lewandowski, Martin Lukas, Magdalena Kaniewska, et al.
Gastrointestinal Endoscopy|July 16, 2025
ResponseKonrad Lewandowski, Martin Lukas, Magdalena Kaniewska, et al.
Przeglad Gastroenterologiczny|April 20, 2026
RESCUE-CD - Real-world effectiveness of risankizumab in moderate-to-severe Crohn's disease: a case series involving the most refractory and challenging patientsKonrad Lewandowski, Katarzyna Karłowicz, Joanna Sarbinowska, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 21, 2025
Efficacy of Microencapsulated Sodium Butyrate as Add-On Therapy in Inducing Remission in Patients with Mild-To-Moderate Ulcerative Colitis: Results From a Multi-Center, Double-Blind, Randomized, Placebo-Controlled StudyKatarzyna Karłowicz, Konrad Lewandowski, Magdalena A Kaniewska, et al.
Journal of Clinical Medicine|March 17, 2025
Efficacy of Upadacitinib Induction Treatment in Moderate-to-Severe Ulcerative Colitis Including Intestinal Ultrasound Assessment: A Multicenter, Real-World Observational StudyMagdalena Kaniewska, Konrad Lewandowski, Michał Krogulecki, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Przeglad Gastroenterologiczny|January 15, 2025
Ophthalmological manifestations in inflammatory bowel disease under the watchful eye of a gastroenterologist from a tertiary centreKonrad Lewandowski, Magdalena Kaniewska, Katarzyna Karłowicz, et al.
Polish Archives of Internal Medicine|July 1, 2024
Dermal lesions associated with anti-tumor necrosis factor α therapy in patients with inflammatory bowel disease (IBD): findings from a tertiary IBD center in PolandKonrad Lewandowski, Magdalena Kaniewska, Martyna Więcek, et al.
Pharmacological Reports : PR|April 17, 2024
Pharmacokinetic interaction between regorafenib and atorvastatin in ratsDanuta Szkutnik-Fiedler, Edyta Szałek, Filip Otto, et al.
Przeglad Gastroenterologiczny|June 28, 2024
SARS-CoV-2 vaccination in inflammatory bowel disease (IBD) patients - does treatment for IBD negatively affect SARS-CoV-2 antibodies? A single-centre, prospective studyKatarzyna Karłowicz, Konrad Lewandowski, Edyta Tulewicz-Marti, et al.
Gastrointestinal Endoscopy|March 5, 2025
Risk factors for difficult endoscopic bowel dilation of predominantly shorter and noninflammatory strictures among patients with inflammatory bowel disease: findings from inflammatory bowel disease tertiary centers in Poland and Czech RepublicKonrad Lewandowski, Martin Lukas, Magdalena Kaniewska, et al.
Gastrointestinal Endoscopy|July 16, 2025
ResponseKonrad Lewandowski, Martin Lukas, Magdalena Kaniewska, et al.
Przeglad Gastroenterologiczny|April 20, 2026
RESCUE-CD - Real-world effectiveness of risankizumab in moderate-to-severe Crohn's disease: a case series involving the most refractory and challenging patientsKonrad Lewandowski, Katarzyna Karłowicz, Joanna Sarbinowska, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 21, 2025
Efficacy of Microencapsulated Sodium Butyrate as Add-On Therapy in Inducing Remission in Patients with Mild-To-Moderate Ulcerative Colitis: Results From a Multi-Center, Double-Blind, Randomized, Placebo-Controlled StudyKatarzyna Karłowicz, Konrad Lewandowski, Magdalena A Kaniewska, et al.
Journal of Clinical Medicine|March 17, 2025
Efficacy of Upadacitinib Induction Treatment in Moderate-to-Severe Ulcerative Colitis Including Intestinal Ultrasound Assessment: A Multicenter, Real-World Observational StudyMagdalena Kaniewska, Konrad Lewandowski, Michał Krogulecki, et al.
Pageof 4